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 Globally there is limited research concerning women who inject drugs. 
 
 This paper reports important insights related to the experiences, needs and barriers 
preventing the utilisation of reproductive maternal, neonatal and child health services 
among women who inject drugs in coastal Kenya. 
 
 Findings from this study will inform the development of equitable, comprehensive, 
and family-centered RMNCH interventions targeting women who inject drugs, 







The Kenyan government has committed to increasing access to comprehensive reproductive, 
maternal, neonatal and child health (RMNCH) services. However, inequalities still exist. 
Women who inject drugs are an important sub-population for public health interventions, yet 
their RMNCH needs have largely been overlooked. Additionally, there is a lack of research 
to inform RMNCH interventions for this sub-population.  
Methods:  
In 2015, we undertook interviews and focus group discussions with 45 women who inject 
drugs and five key stakeholders to understand these women’s RMNCH experiences and 
needs.  
Results:  
Women’ access to essential services across the RMNCH continuum was low. Two thirds of 
the women were not using contraception. Many discovered they were pregnant late, due to 
amenorrhea of drug use, and thus were unable to enroll for antenatal care early. Facility-
based deliveries were limited with many choosing to deliver at home. Following delivery, 
women’s attendance to immunization services was sub-optimal. Stigma from healthcare 
workers was a major factor impeding women’s use of existing RMNCH services. The 
prospect of experiencing withdrawals at health facilities where waiting times were long, 
deterred utilization of these services. Additionally, women faced competing priorities, having 
to choose between purchasing heroin or spending their money on health-related costs. 
Conclusions:  
Several barriers disrupted women’s access to services across the RMNCH continuum. 
Consequently, there is a need to develop equitable, comprehensive, and family-centered 
RMNCH interventions tailored to women who inject drugs, through a combination of supply- 
and demand-side interventions. For optimal impact, RMNCH services should be integrated 
into harm reduction programs. 
 
 




Significant progress has been made over the last decade in relation to reproductive, maternal, 
neonatal and child health (RMNCH) outcomes [1]. Despite this progress however, maternal 
and child mortality are still among the leading causes of global burden of disease [2, 3]. 
Recent data suggest that globally, 275, 000 maternal deaths, 2.6 million neonatal deaths and 
still births, and 5.8 million under-five children deaths occur annually [2, 4]. Consequently, 
improving RMNCH outcomes remains a contemporary global health priority [2, 5]. In 
particular, there is global consensus that increasing availability and utilization of 
comprehensive RMNCH services is essential in achieving the Sustainable Development 
Goals and targets by 2030. 
 
Eliminating maternal, neonatal, and early childhood mortality requires addressing persistent 
health systems weaknesses which are stalling further RMNCH progress. These include poor 
availability and quality of services  [6, 7]. Investments in health care in sub-Saharan Africa 
and other low-income countries remain low (ref). In many low-income countries, 
fragmentation of services has consistently caused variations in coverage of RMNCH 
interventions, and prevents the multiplier benefit of combining interventions through 
integrated packages from being realized [5]. Not surprisingly, there is growing consensus that 
adopting a continuum of care approach could significantly accelerate progress in RMNCH 
outcomes  [5]. The continuum of care approach recognizes the links from mother to child, 
and the need for health services across maternal, neonatal, and child stages of life  [5, 8]. Its 
proponents assert that these services ought to be integrated and continuous, rather than 
isolated [5].  
 
In addition, attention is now turning to whether the RMNCH achievements recorded to date 
have been equitable and inclusive [9]. Studies focusing on RMNCH have uncovered 
  
substantial inequalities in coverage between interventions, geographic regions, countries and 
populations [1, 9, 10]. Variability in coverage of maternal, newborn, and child health 
interventions have been found to be larger among the poor compared to wealthier groups of 
individuals [10]. Globally, women from underserved socioeconomic and geographical strata 
– who often have low income per capita, low educational attainment, and high fertility rates – 
are unevenly reached by health services [2], and as a result, they typically have worse 
maternal and infant outcomes [11]. 
 
In Kenya, the government has made a commitment to increase access to comprehensive 
reproductive health services, including skilled birth attendance, prenatal care, emergency 
obstetric care and post-natal vaccinations, through free maternal healthcare [12, 13]. 
Although out-of-pocket expenditures for maternity care are reducing, they have not been 
entirely eliminated [13]. Furthermore, although 96% of pregnant women receive antenatal 
care, just over half (58%) make the recommended four or more antenatal care visits [14]. 
Additionally, less than two thirds (61%) of all births in Kenya are delivered in a health 
facility (61%), and a similar proportion (62%) are assisted by a skilled provider [14].  
 
In addition, coverage of full immunization is 79% [14], which creates conditions for vaccine-
preventable childhood illnesses to thrive. Not surprisingly, infant mortality rate is 39 deaths 
per 1,000 live births, and under-five mortality is 52 deaths per 1,000 live births. Furthermore, 
access to reproductive and family planning services is sub-optimal, with a modern 
contraceptive prevalence of 53% [14]. Overall, 18% of currently married women have an 
unmet need for family planning [14]. As in other countries investments in basic healthcare 
systems in Kenya remains insufficient [15]. The health human resources to population ratio is 
13/10,000 population compared with the WHO-recommended threshold ratio of 23/10,000 
  
population [16, 17]. Partly as a result of these deficiencies, Kenya did not meet her MDG 4, 5 
and 6 targets [18].  
 
In Kenya and other countries, inequalities in access to RMNCH services exist [18]. 
Therefore, monitoring the coverage of health interventions in vulnerable subgroups of the 
population is essential in ensuring equity [9]. In this context, women who inject drugs 
represent an important sub-population for public health interventions, yet their broader sexual 
health and RMNCH service needs have largely been overlooked due to a narrow yet 
important focus on HIV prevention and harm reduction services that are primarily concerned 
with limiting the negative effects of injecting drug use [19-21]. Literature suggests that 
women who inject drugs are particularly affected by inequalities in access to health services 
globally [22, 23]. A significant majority of the 3.5 million women who inject drugs 
worldwide are of reproductive age [24, 25]. Yet, these women typically have extremely poor 
access to essential RMNCH health services such an antenatal care (ANC) compared to non-
injecting women [23, 26]. 
 
At present, there is a lack of research on women who inject drugs in Kenya that could inform 
potential RMNCH interventions for this sub-population [27]. In response to this knowledge 
gap, the aim of this study was to document the RMNCH experiences and needs of women 




This study utilised qualitative focus group discussions (FGDs) and in-depth interviews (IDIs) 
with women who inject drugs and key stakeholders in the coastal Kenyan towns of Kilifi and 
  
Mombasa. The combinations of IDI and FGDs, and the inclusion of key stakeholders as 
informants alongside the women, was intended to avail complementary information for 
triangulation purposes [28]. 
 
Setting 
In the above two coastal towns, community-based services had been introduced to serve 
injecting drug users by the Kenya AIDS NGOs Consortium (KANCO), a local non-
governmental organization. Services were being provided through two community-based 
organizations (CBOs): Reach out Centre Trust (REACH OUT) and the Muslim Education 
and Welfare Association (MEWA). In 2012, these sites formed part of a pilot implementation 
of a new community-based harm reduction service delivery approach. As opposed to relying 
on drug users to attend health facilities, outreach workers reached out to injecting drug users 
in their own localities, and provided them with information on HIV and the risks associated 
with injecting drug use, as well as providing clean needles and syringes [29]. Outreach 
workers also referred injecting drug users to the two linked CBOs where primary health and 
HIV services were provided. The two CBOs also served as drop-in centres, offering 
temporary shelters, first aid from withdrawals, and screening for Human Immunodeficiency 
Virus (HIV) and other Sexually Transmitted Infections (STIs). In mid-2014, the outreach 
program was expanded to include sexual and reproductive health (SRH) services. Services 
provided to injecting drug users are summarised in Table 1. 
 
Table 1. Nature and scope of services provided to women who inject drugs by CBOs. 
Service domain Interventions and services 
provided during outreach 
Interventions and 
services provided at 
drop-in centres 
Referrals to private and 
government health and 
social services 
Prevention and 
treatment of HIV 
and co-infections  
Condoms, HIV testing, 
information, communication 
and education (IEC) on HIV 
HIV testing and 
counselling services.  
Confirmation of HIV, 
antiretroviral therapy 
(ART), and testing for 
  
and sexually transmitted 
infections (STIs). 
hepatitis C and 
Tuberculosis (TB). 
Harm reduction Clean needle and syringes, 
alcohol swab, cotton wool. 
Addiction counseling and 
first aid for violence and 
overdose. 
Referrals for medically 
assisted therapy (MAT)/ 
opioid substitution 








rarely, provision of oral 
contraceptive pills. 
Pre-natal education, 
provision of short term 
reversible contraceptives.  
Referral for long term 
contraceptives, ante-natal 
care, and cervical cancer 
screening. 
Social and child 
related care 
services 
Transport, personal care 
kits. 
Personal care (shower 
soap, toothbrush, 
toothpaste, lotions), short 
term shelter and diapers 
for women with children. 
Referrals for sexual 




Women who inject drugs were approached by outreach workers in the course of outreach, 
informed about the study and, if interested, screened for eligibility. Eligible participants were 
scheduled for IDIs and FGDs. To be included, participants had to: be an adult aged at least 18 
years; be of reproductive age (i.e. <50 years); and, have been injecting drugs within the 90 
days prior to participating in the study, which was the operational definition of active 
injecting drug use. Overall, 45 women who injected drugs were involved in the study. Of 
these, 24 participated in IDIs (12 in each site) and 21 participated in three FGDs (2 sessions 
in Mombasa and 1 session in Kilifi). 
 
In addition to the women, five individual key stakeholders were invited to participate in IDIs. 
These stakeholders were purposively sampled in collaboration with the CBOs, based on their 
expertise in policy and service delivery for injecting drug users. The key stakeholders 
included a community health worker (n=1), outreach workers (n=2), a Ministry of Health 




Data collection took place in 2015. All IDIs and FGDs were by undertaken by experienced 
researchers, JN and SA. These two researchers had been involved in research and service-
provision with injecting drug users, and had good understanding of the issues faced by this 
population. Data collection was conducted in Swahili (the national language of Kenya) or 
English, depending on participants’ preferences. Data were collected in private rooms on the 
premises of the CBOs or in stakeholders’ offices. IDIs and FGDs were audio recorded and 
lasted between 45 and 60 minutes.  
 
Semi-structured topic guides were developed to guide the IDIs and FGDs, which were piloted 
for clarity and acceptability of language, and revised based on feedback. These discussion 
guides were developed in reference to on existing literature and the study aim of this study. 
As such, topic guides explored past and current drug use history, experiences with 
contraception, pregnancy and pregnancy termination, reproductive and sexual health, HIV 
testing, immunization and vaccination, and perceived barriers to accessing RMNCH services. 
For stakeholders, topic guides focussed on policy and community service aspects related to 
women who inject drugs. At the end of IDIs and FGDs, brief standardized set of questions 
were used to collect basic socio-demographic data from participants.  
 
Data analysis 
Socio-demographic data were entered into Excel and summarised. Data from IDIs and FGDs 
were translated and transcribed into English simultaneously and as appropriate, and all 
transcripts were then imported into Nvivo (QSR International) [30]. Thematic analysis was 
used to identify pertinent themes that emerge from the IDIs and FGDs [31]. Coding was 




Participation in this study was voluntary, and written informed consent was obtained from 
each study participant after a being provided with a detailed description of the study objective 
and procedures. Data were collected in private rooms to safeguard confidentiality. 
Participants were informed that they could stop responding to questions and discontinue their 
participation at any time. Rigorous strategies were used to protect confidentiality and data 
were stored in password protected folders and computers. Ethical review and authorisation 
for this research was provided by the National Commission for Science Technology and 
Innovation (NACOSTI, ref: P/15/8861/4510). 
 
RESULTS 
Participant Characteristics  
As shown in Table 2, the average survey respondent was in her late twenties, with a mean 
age of 28.5 years. The average participant had a low level of education. Almost a fifth (18%, 
n=8) had no formal education, half (51%, n=23) had attended a primary school, and 27% 
(n=12) had some secondary education. Only one participant had post-secondary education. 
The commonest sources of income were sex work (29%, n=13), ‘hustling’ or begging (24%, 
n=11), and casual labour (16%, n=7).   
 
On average, participants had used different substances and drugs for a cumulative eight and a 
half years, but had used drugs by way of injecting for the last two and a half years. The 
primary drug injected was heroin, which was used by 85% (n=38) of participants. Polydrug 
usage was common, with 60% (n=29) of the participants using multiple substances. All 
  
except seven women had at least one living child (mean 1.6; range 1–5). Overall, more than 
two-thirds (69%, n=31) of the participants were not using contraceptives. 
 
Table 2. Participant Characteristics. 
Characteristic IDI FGDs Total  % 
Age (mean, years) 26.4 30.5 28.4 - 
Number of children (mean)   1.6 - 
Education 
None 4 4 8 18% 
Primary  13 10 23 51% 
Secondary 6 6 12 27% 
Post-secondary 0 1 1 2% 
Unknown 1 0 1 2% 
Marital status 
Married 5 3 8 18% 
Live in partner 7 5 12 27% 
Single 11 13 24 53% 
Unknown 1 0 1 2% 
Income source 
Casual labor 2 5 7 16% 
Food Kiosk/plaiting 3 2 5 11% 
Sex work 9 4 13 29% 
Peddling 1 2 3 7% 
Peer educator 0 1 1 2% 
  
Family or partner 3 1 4 9% 
Begging, hustling 5 6 11 24% 
Unknown 1 0 1 2% 
Drug use 
Duration using drugs (years) 7.8 9.1 8.5 - 
Duration injecting (years) 3.3 2.0 2.6 - 
Main drugs used 
Heroin 11 1 12 27% 
Heroin, and other drugs 11 15 26 58% 
Cocaine 1 3 4 9% 
Cocaine and other drugs  1 2 3 6% 
Currently using contraception 
Yes (including condoms)   14 31% 
No   31 69% 
 
Experiences and utilization of services along the continuum of RMNCH  
As described in the following section and in Table 3, the results showed a number of critical 
issues for women who inject drugs that relate to their use and experiences of RMNCH 
services. Pregnancies were often discovered late, due to amenorrhea, which delayed 
awareness and implementation of key measures to protect the health of the child. The use of 
key RMNCH services like ANC check-ups, facility-based delivery services, and 
immunisation/vaccination was sub-optimal, and was affected by the stigmatising attitudes of 
staff, experiences of withdrawal symptoms and the competing priorities of health care versus 
drug use in terms of allocating time and money. Additionally, stakeholders articulated a need 
for integrated and linked RMNCH services for women who inject drugs. 
  
 
Low utilisation of services along the RMNCH continuum. 
Data suggested that in general, utilization of pre-natal, facility delivery and post-natal 
services such as immunization was sub-optimal. To start with, attendance for ANC check-ups 
was poor, inconsistent or late. Very few women reported having attended ANC clinics. 
Others “went only one time to get a card, so as not to get any problem when giving birth” 
(Participant  7, Mombasa). Low attendance of ANC was also noted by stakeholders, who 
stated that “when pregnant, they rarely go for antenatal care” (Stakeholder  1, Outreach 
Worker, Mombasa).  
 
Similarly, it was common to hear accounts of how women “gave birth at home” (Participant 
 5, Kilifi and Participant  6, Mombasa). Some women had delivered more than one child as 
illustrated in Table 3. In some cases, these deliveries were attended by traditional birth 
attendants, as was the case of one participant who reported that “my mother was a traditional 
birth attendant, she used to help mothers giving birth” (Participant  6, Mombasa). However, 
in other cases, there were no birth attendants (neither traditional nor skilled) at the delivery, 
and often women only attended a health facility following childbirth. For instance, asked who 
assisted her, a participant stated: “I gave birth alone and then I went to hospital the next day” 
(Participant  1, Kilifi). 
 
A mixed picture emerged regarding immunizations. While some women reported that they 
had taken their children to all immunizations, others reported that the they had missed 
immunizations, while yet others reported that they “never went for them” (Participant  11, 
Kilifi). On their part, outreach workers agreed that poor utilisation of ANC services among 
this population was a significant challenge, and explained how they were intervening: “in 
  
case they are pregnant, we have to go and bring them for the antenatal services until the day 
they are almost giving birth. We take them to Coast General Hospital” (Stakeholder  1, 
Community Health Worker, Kilifi).  
 
Table 3. Themes regarding experiences and utilization of RMNCH services 
Themes Codes Illustrative quote 
Low utilisation of 
RMNCH services 
Low or late attendance of 
ANC. 
“At times they go up to delivery and they have never 
attended any clinic, which is so dangerous…We 
should start early interventions during pregnancy, you 
know?” (Stakeholder  1, Outreach Worker, 
Mombasa). 
Preference for home 
delivery/low facility 
delivery. 
“Like the other child, I just gave birth at home” 
(Participant, FGD 2, Mombasa), 
Absence of skilled birth 
attendant. 
“Haha. I gave birth at our home, and Khadija [a 
friend] came to pick me, then then we proceeded to [a 
clinic in] Kilifi” (Participant  9, Kilifi) 
Missed immunizations. “I don’t want to lie to you; I took the baby for 




Lack of information. “You would expect them to have the right knowledge, 
right information so that, they can make a decision 





“They tell each other “that is a drug user””, they take 
you round from one place to another once they know 
you are a drug user, and you end up being the last one 
to be served” (Participant # 5, Kilifi). 
Cost. “I had a medical bill at the hospital that I never paid 
for, I was paid for by the government. From hospital, I 
called my mother and she sent fare, I went to home” 
(Participant  1, Mombasa). 
Late discovery of 
pregnancy due to 
amenorrhea. 
“When we use drugs, it usually prevents someone 
from getting pregnant, because it usually prevents us 
from getting periods. It can take for more than two 
years you have not had periods. I don’t know what it 
is usually happening” (Participant # 8, Kilifi). 
Failure to remember 
appointments due to drug 
use. 
“It is heroin. Heroin causes all this. Even seeking for 
health services, I don’t, ahh! I just see I’m alright. 
Even making follow-ups, I don’t” (Participant  9, 
Kilifi). 
Drug withdrawals. “Since I had ‘arosto’ [drug withdrawal] and could not 
queue, I just left” (Participant # 10, Mombasa). 




for women who use 
drugs and their 
families. 
RMNCH into harm 
reduction and HIV 
services. 
drugs] is not enough without addressing reproductive 
health” (Stakeholder  1, Outreach Worker, 
Mombasa). 
Failure to integrate issues 
of children of women 
who use drugs. 
“In our rehabilitation strategy, we should have a 
component that will address mothers who are into 
drugs with their children” (Stakeholder  1, Outreach 
Worker, Mombasa). 
 
Barriers to access to services  
Another theme that emerged from the data related to barriers preventing women from 
utilising RMNCH services. To start with, it was suggested that women lacked information 
about the benefits of ANC, yet “they ought to attend clinics when they conceive. They should 
go for check-ups so that they can be advised on how to take care of their pregnancy” 
(Stakeholder  1, Outreach Worker, Mombasa). Not surprisingly, women seemed to prioritise 
their drug use over their own health. Asked why she missed her appointments, one participant 
rhetorically asked “will you take 40 shillings to go to the hospital or will you first look for 
drugs?” (Participant # 5, Kilifi). 
 
In addition, stigmatising attitudes from health care workers was blamed for low attendance at 
ANC and post-natal clinics. Reporting her interactions with health providers, a participant 
reported that “they despise us a lot.” She added that: 
Should they know that you are an addict, they send you backwards on the queue or 
tell you to go and come later. (Participant # 10, Kilifi). 
The importance of stigma was emphasised by ways in which participants contrasted health 
care workers’ attitudes vis-a-vis that from outreach workers. Referring to outreach workers 
from one of the CBOs, a participant reported that “the outreach workers are okay. They don’t 
have anything against us. If you have problems you tell them, they will help you”. (Participant 
# 6, Kilifi). Another opined that “people from REACHOUT care. If you have any problem or 
if you are not feeling well, they will write for you a referral to go to hospital if they do not 
  
have the ability to treat you. If you get there you will be treated because of their referral. So I 
see they help”. (Participant  7, Mombasa).  
 
Not surprisingly, stakeholders asserted that the low attendance of ANC and immunization 
appointments was also because of women’s drug use:  
Because of their drug use, they conceive and can even stay for up to six months 
before going for antenatal care (Stakeholder  1, Outreach Worker, Mombasa). 
Consistent with these claims, some women also blamed their drug use for such missed 
appointments. Asked whether she had taken her child to all immunizations, one participant 
responded: 
All the immunizations? I don’t think I took him to have all the immunization 
injections. There are those that he skipped, I don’t remember. I don’t even know 
where the cards we use at the clinic are. Have you ever seen a life that is shattered? I 
don’t remember anything (Participant  1, Kilifi). 
 
Women were cognizant of the impact of drug use on their ability to seek or attend RMNCH 
services, with several mentioning that they hardly remembered their appointment dates. In 
their lives, getting access and using drugs was prioritised, and often this meant that 
appointments were not kept. In a typical statement one participant stated that “at times I am 
passed [by the appointment] because I can’t remember much” (Participant  10, Mombasa). 
Asked about what would assist her to follow-up on her own and her child’s health 
appointments, another participant responded: 
Stopping these issues of drug abuse. That is when I can follow-up on services. 
Without stopping drugs, there is nothing I can follow-up on (Participant  9, Kilifi). 
  
Given these observations, it is not surprising that stakeholders emphasized the need for 
systems to remind women about immunizations. Asked if women brought their children to 
the clinic, a stakeholder stated that “they do come with them here, but the problem is that they 
forget. They don’t have the memory to remember the baby has to go [for immunization]. So 
we go back to the field to remind them” (Stakeholder  1, Community Health Worker, Kilifi).  
 
Due to their ongoing drug injecting, women reported that they experienced amenorrhoea, 
which in-turn interfered with their ability to know if they were pregnant when they missed 
their periods. For instance, one participant explained that she had missed her ANC because 
she discovered her pregnancy late “I realized I was pregnant when I was almost going to 
deliver. Eeeh! After seven months.” (Participant  11, Kilifi). This phenomenon was also 
observed by a stakeholder who asserted that “when they are pregnant, they do not know that 
they are pregnant” (Stakeholder  1, Community Health Worker, Kilifi).  
 
Another barrier to use of services was related to costs. Indirect costs associated with facility-
based delivery were particularly influential of women’s decisions to give birth at home. The 
importance of previous user fees came to the fore given the fact that in contrast to previous 
years, free maternal services were now available, as a participant noted:  
Nowadays there is no paying for delivery services. It’s free of charge to deliver, if you 
go to Makadara. If you go there, they don’t ask for anything. You give birth for free. 
You carry your child and go your way. But during the previous time when payments 




Despite the free maternal health care however, women suggested that delivering at the 
hospital always invariably came with some hidden costs, as they were frequently prescribed 
medications, which they then had to buy: 
You are forced to pay. If you go, you must buy medication! If you go to the hospital 
then you are given a prescription, you have to buy using your own money at the 
chemist. (Participant, FGD 2, Mombasa). 
 
Apart from potential indirect costs, the prospect of having drug withdrawals while at health 
facilities discouraged women from attending appointments, especially when queues were 
expected as illustrated in Table 3. In addition, accounts of women, particularly those who 
had had caesarean sections suggested that withdrawal symptoms emerged during the post-
natal period, often interfering with the care they received. In an illustrative example, a 
participant narrated how she “had to be operated upon” but at the hospital, “issues of drug 
use” came up (Participant  12, Kilifi). She explained that she had a negative experience and 
“had to persevere, because I was falling often like a leper” due to drug withdrawals. 
 
Lack of integrated and holistic services along RMNCH continuum  
Data suggested that part of the reason for the low utilisation of RMNCH services was the 
lack of a holistic view of the health needs of women who inject drugs.  Harm reduction 
services were not generally catering for the sexual and RMNCH needs of women, prior to the 
pilot that was started in 2014: 
We didn’t have a specific package for females, and there was no project that was 
addressing issues of women. So we started implementing this innovative SRH project, 
which has brought great mileage. (Stakeholder  1, Outreach Worker, Mombasa). 
  
In the words of this stakeholder, the lack of SRH services for women who inject drugs was “a 
great challenge, because females who use drugs are not given a right, to decide when, they 
should get pregnant” (Stakeholder  1, Outreach Worker, Mombasa).  
 
In addition, another stakeholder explained that these gaps occurred because “the health care 
workers did not understand why and how they needed to serve female drug users”. 
(Stakeholder # 3, CBO Program Manager, Kilifi). Addressing the health issues of women 
who inject drugs was not seen as sufficient unless it includes reproductive health services for 
women as illustrated in Table 3. Furthermore, there were misconceptions and false 
assumptions that women who inject drugs were not sexually active or did not reproduce, 
which was blamed for the neglect of sexual and RMNCH services for this population. As one 
stakeholder asserted:  
There has been a lot of misconception that females who use drugs are not sexually 
active, that they do not reproduce, but these are mere misconceptions and myths that 
the communities have. The reality is when they are informed, they can take actions 
which are highly informed. If they get knowledge, they get informed, then they can 
make some decisions upon their reproductive life (Stakeholder  1, Outreach Worker, 
Mombasa). 
 
A lack of a holistic approach to the health of these women also meant that they did not have 
access to child support services. In a good number of cases, women left their children to be 
looked after by their own parents, while they continued with their drug use. An example is a 
participant who reported how her child was being taken care of by her “mum” while she 
“returned to drug use” (Participant  12, Kilifi). In addition, it was clear that a lack of 
integrated services caused missed opportunities for child health services, for example in 
  
relation to HIV testing, which is particularly important given that women who inject drugs 
are at high risk of HIV in the study context. One participant illustrated this by mentioning 
that: 
I got pregnant when I was [using drugs] like this, and I gave birth at home. The child 
was not tested…I just started taking the baby for the immunization without being 
tested for HIV…but the child started becoming sick (Participant  5, Mombasa). 
 
This deficiency in integration of services and lack of a holistic approach to the continuum of 
RMNCH interventions was also said to affect wider issues of child welfare. Stakeholders 
suggested that a lack of focus on the children of women who injected drugs was a 
“challenge… because the families are being raised in an unfavourable environment… a 
family which has nowhere to live, except in the streets” it was suggested that services 
targeting women who inject drugs “should have a strategy to address issues of both the mom 
and the child”  (Stakeholder  1, Outreach Worker, Mombasa). This stakeholder was of the 
view that “in our rehabilitation strategy, we should have a component that will address 
mothers who are into drugs with their children”. This was due to the observations that many 
children were separated from their mothers, who stakeholders felt “have a right to be under 
the custody of their mothers” (Stakeholder  1, Outreach Worker, Mombasa). 
 
DISCUSSION  
This study documents the experiences and needs of women who inject drugs in relation to 
their access to RMNCH services, and highlights that there are significant supply and demand 
side issues to be considered in program interventions. The sub-optimal use of RMNCH 
services documented in this study have also been observed among non-drug-using women in 
many other setting in sub-Saharan Africa. These include barriers that reduce demand for 
  
these services among women, such as lack of awareness about complications in pregnancy or 
need to attend ANC [33], lack of knowledge of the benefits of skilled/facility-based delivery 
[33, 34], low health seeking behaviours and delays therein [33], and long distances or lack of 
transportation to the health facilities [33-36].  
 
Other barriers operate to reduce supply, affordability and availability of these services. These 
include out-of-pocket health expenditures [33], inattention to reproductive health and rights 
[37], poor quality of health care [37], inadequate staffing [38], and lack of training of health 
providers [36], fear of being neglected or maltreated by health workers [34, 36]. Our study 
adds onto existing literature showing that women who inject drugs may particularly be 
affected by these barriers [23, 26, 39]. In light of these findings, we suggest that interventions 
focusing on both supply and demand and appropriate RMNCH interventions will be required. 
 
Strengthening the supply and availability of integrated RMNCH interventions to 
women who inject drugs  
An efficient and effective health care system requires an accessible health care delivery 
system that provides appropriate services to all populations, including marginalized 
populations, where and when they need them [40]. Our study points to a number of health 
systems weaknesses and barriers preventing the utilization of RMNCH interventions. 
Therefore, health systems need to be strengthened and adapted so as to be responsive to 
health needs of women who inject drugs. At a macro level, this will also require enhanced 
investments in health sector across all elements of the health system [40, 41]. This is 
particularly critical in Kenya, where the current expenditure in health is below the 2001 
Abuja declaration which recommended 15% of the annual national budget to be set aside for 
health [42]. In addition, it will be essential to strengthen health information systems so as to 
  
include user fields that allow tracking of equity in reach of health services. Monitoring the 
coverage of health interventions in subgroups of the population is critical because national 
averages can hide important inequalities [9]. Given the low ratios of health providers, further 
expansion of the health work force will be essential to mitigate current shortage [41]. 
 
At a micro level, training of health providers regarding the needs of women who inject drugs 
will be essential. Evidence from the study setting suggests that health providers do not know 
how to attend to women who inject drugs, as they are unfamiliar with their health needs and 
issues, such as methadone, withdrawals, and amenorrhea, among others. Addressing 
misconceptions documented in our study and elsewhere [19, 43] that women who inject 
drugs are not active sexually or that they cannot have responsible control over their own 
reproductive and maternal health will be necessary. In addition, our study suggests that given 
the poor reach of formal health services to these marginalized population, adapting the local 
delivery system so as to reach them in their localities will be critical in achieving equitable 
access to essential RMNCH services.  
 
In a recent review of maternal, newborn, and child health services, community-based 
interventions were more equally distributed than those delivered in health facilities [10]. 
Therefore, ensuring that services are delivered outside of health facilities and as much as 
possible in the community will be a critical determinant of whether marginalized populations 
are reached with essential services. In this regard, integrating reproductive, maternal, 
neonatal services into harm reduction programs will be needed, as recommended by others 
[44]. In 2006, the Ministry of Health formally recognized the importance of linking 
communities and front line facilities and launched the Community Health Strategy. Five 
years later, in 2013, the Ministry launched the Harm Reduction Strategy [45]. Our assertion is 
  
that to achieve optimal outcomes, these strategies will need to be operationalized via 
community-based harm services that include RMNCH interventions, and are provide women 
who inject drugs in their own localities.  
 
Increasing demand and utilization of integrated RMNCH interventions by women who 
inject drugs  
 
Addressing health systems alone is not sufficient to address determinants of RMNCH service 
utilization, at least based on our study findings. At a macro level, advocating for the 
reproductive health and rights of women a basic human rights entitlement at the national 
level will be important in driving macro-level demand, and ensuring that the government can 
meet its obligations to international human rights commitments, particularly those pertaining 
to sexual and reproductive health and rights (SRHR) of women. Addressing issues of cost 
will require ensuring that user fees are eliminated in keeping with the government’s 
commitment for free maternal healthcare, and indirect costs, such as transport costs or 
purchasing of prescriptions, are minimised. In addition, strengthening community systems 
and infrastructure will drive the demand of RMNCH services. Evidence from recent reviews 
shows that interpersonal and community-based interventions are effective in increasing the 
demand and uptake of RMNCH services [46], for example through site and home visits [46, 
47].  
 
Based on the findings from this study, a significant number of barriers can be addressed by 
integrating RNMCH interventions into outreach-based harm reduction programs. The 
closeness of outreach workers to the women who inject drugs can facilitate the tracking and 
provision of essential RMNCH interventions across the RMNCH continuum of care. Our 
  
recommendation is that community-based outreach services should 1) ensure early 
identification of pregnant women including through pregnancy testing, and newborn babies; 
2) link pregnant women to ANC, 3) support the retention of pregnant women in ANC 
attendance through site visits and appointment reminders (e.g. via text messages), 4) screen, 
recognize and refer pregnancy-related complications (e.g. pre-eclampsia, haemorrhage, 
premature rupture of membranes, and infections) for management at referral facilities, 5) 
assist women to have a birth plan that supports facility-based delivery or at least assisted by a 
skilled birth attendant, 6) identify post-natal women who may have missed ANC and link 
them and their newborn babies to post-natal care, 6) integrate post-natal follow up and home 
visits to harm reduction outreach activities, 7) follow up and provide reminders to women to 
ensure that they adhere with immunization schedules and, 8) follow up women and their 
children and link them with multifaceted interventions that address needs of children, 
housing, employment among other needs. This will require multi-sectoral collaboration.  
 
At a micro level, reaching, informing and educating women on issues regarding RMNCH 
will increase their awareness. Mobilizing and training them to seek, demand and utilise 
RMNCH services will be an important second step. Interpersonal education and information 
strategies are effective in increasing uptake of maternal and neonatal outcomes [47], and 
these could work well within outreach programs. In addition, there is a need to leverage on 
women's agency and desire to improve their own reproductive health. Women who inject 
drugs should not automatically be imagined as being unable to make informed choices 
regarding their own health and that of their children [43].  
 
Evidence suggests that many drug-using women are keen to achieve or maintain identity as a 
responsible mother, and to live out the values of being a responsible mother [48, 49]. Often, 
  
they are cognizant that drug use is an impediment to these aspirations, and many are 
confronted with fear of hostile social judgements of being an addict mother [48]. Despite 
these adversities however, most of these women aspire to be successful mothers [43, 49]. 
Therefore, leveraging on these motivations and aspirations would be an important and 
transformational strategy through which women can be supported to cope with stigma, self-
blame, and minimize harm from drug use [48, 49], while at the same time improving their 
access to essential RMCH services and outcomes. Demand can also be increased through 
specific incentives. Although financial incentives have been considered in other contexts 
[47], in our context, free pampers for women with children were incorporated at drop-in 
centers to motivate their use of harm reduction and reproductive health services. 
 
Limitations 
Our sample included women who were already being reached with outreach services and may 
have had different experiences. Thus, transferability of our findings to women who inject 
drugs who are not enrolled in outreach services may be limited. In addition, social 
desirability bias may have affected our findings, given that participants were recruited 
through CBOs that encouraged them to seek health services. Methodologically, combination 
of IDI and FGDs was designed to provide complementary data for triangulation purposes. 
However, as might be noted from our findings, women in FGDs were less forthcoming with 
information related to their utilization of RMNCH services, which could be a reflection of 
social desirability bias. Indeed, our findings may be under-estimating the extent of the need 
and barriers related to RMNCH services as women may have been hesitant to report their 
poor health seeking behaviours. Under-reporting of poor health seeking is reported in other 
studies of drug users [50]. This may be particularly important for this study as member 
checking was not conducted in this study. Nevertheless, FGDs and IDIs overlapped in their 
  
often iterative questions, and findings across both methodologies were consistent. In addition, 
findings from both the women and stakeholders were consistent in highlighting the poor 
utilization and wide-ranging barriers to women’s utilization of RMNCH services.   
 
Researchers’ predispositions frequently affects what is reported from studies [28]. To 
safeguard credibility and trustworthiness of our analysis, the coding process was conducted 
by two authors (JN and GM) as recommended by other scholars [31]. These authors were 
familiar with issues of women who inject drugs and services at the CBOs, enabling them to 
contextualise the data appropriately. Quotes are presented in the text to support our 
assertions, and the linkage between these quotes, codes and themes are made clear in Table 3 
to facilitate independent judgement as suggested by Chiovitti and Piran [51]. In addition, 
participants were recruited via two different CBOs through a combination of convenience 
and purposive sampling which enabled the known strengths of these sampling methodologies 
to be harnessed [52], while mitigating researcher bias in participant selection. Despite these 
strategies, it is nearly impossible to eliminate subjectivity in qualitative data analysis [31]. 
Nevertheless, and in spite of potential residual limitations, findings from this study will be a 
useful starting point for improving RMNCH services and policy pertaining to women who 
inject drugs in Kenya. 
 
Conclusions  
Despite recent improvements in maternal, neonatal and under-five health indicators in the era 
of MDGs, significant efforts will be required to ensure equity in RMNCH in the context of 
the new sustainable development goals (SDGs). Women who inject drugs face significant 
challenges in accessing conventional health services. This study reports the sub-optimal 
utilization of services across the continuum of RMNCH by these women. To strengthen 
  
access to these services by these women, specific interventions to support their access at low 
thresholds of interventions across the RMNCH continuum should be prioritized. This will 
require a combination of supply-side interventions that strengthen health systems such as 
equity monitoring, training of health providers and decentralization of services to 
communities, and demand-side interventions such as right-based advocacy, education and 
training of women to seek services, and active screening and referral of pregnant women for 
appropriate RMNCH services. For optimum impact these services should be integrated into 
existing facility- and outreach-based harm reduction services. 
 
Conflict of interests  
Authors declare no conflict of interest. 
 
Authors’ contributions  
GM, JN and SA contributed to the design of the study. JN, SA and SM participated in data 
collection. JN and GM performed the analysis. GM drafted the manuscript. JN, SA, TA, SM, 
FJ and GA reviewed and provided critical input to the paper. The final draft was approved by 
all authors.  
 
Availability of data 
Due to the sensitive and criminalized nature of drug use in the study context, data may not be 







1. Alkenbrack S, Chaitkin M, Zeng W, Couture T, Sharma S. Did Equity of Reproductive and 
Maternal Health Service Coverage Increase during the MDG Era? An Analysis of Trends and 
Determinants across 74 Low- and Middle-Income Countries. PloS one. 2015;10(9):e0134905. 
doi:10.1371/journal.pone.0134905. 
2. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic 
analysis for the Global Burden of Disease Study 2015. Lancet (London, England). 
2016;388(10053):1775-812. doi:10.1016/s0140-6736(16)31470-2. 
3. Global, regional, and national life expectancy, all-cause mortality, and cause-specific 
mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of 
Disease Study 2015. Lancet. 2016;388(10053):1459-544. doi:10.1016/s0140-6736(16)31012-
1. 
4. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, 
and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease 
Study 2015. Lancet. 2016;388(10053):1725-74. doi:10.1016/s0140-6736(16)31575-6. 
5. Black R, Laxminarayan R, Temmerman M, Walker N. Reproductive, Maternal, Newborn, 
and Child Health. Disease Control Priorities, 3rd ed., Vol 2. Washington, DC: World Bank; 
2016. 
6. Yakoob MY, Ali MA, Ali MU, Imdad A, Lawn JE, Van Den Broek N et al. The effect of 
providing skilled birth attendance and emergency obstetric care in preventing stillbirths. 
BMC public health. 2011;11 Suppl 3:S7. doi:10.1186/1471-2458-11-s3-s7. 
7. McClure EM, Pasha O, Goudar SS, Chomba E, Garces A, Tshefu A et al. Epidemiology of 
stillbirth in low-middle income countries: a Global Network Study. Acta obstetricia et 
gynecologica Scandinavica. 2011;90(12):1379-85. doi:10.1111/j.1600-0412.2011.01275.x. 
8. Kikuchi K, Ansah EK, Okawa S, Enuameh Y, Yasuoka J, Nanishi K et al. Effective Linkages of 
Continuum of Care for Improving Neonatal, Perinatal, and Maternal Mortality: A Systematic 
Review and Meta-Analysis. PloS one. 2015;10(9):e0139288. 
doi:10.1371/journal.pone.0139288. 
9. Barros AJ, Victora CG. Measuring coverage in MNCH: determining and interpreting 
inequalities in coverage of maternal, newborn, and child health interventions. PLoS 
medicine. 2013;10(5):e1001390. doi:10.1371/journal.pmed.1001390. 
10. Barros AJ, Ronsmans C, Axelson H, Loaiza E, Bertoldi AD, Franca GV et al. Equity in 
maternal, newborn, and child health interventions in Countdown to 2015: a retrospective 
review of survey data from 54 countries. Lancet. 2012;379(9822):1225-33. 
doi:10.1016/s0140-6736(12)60113-5. 
11. Ruiz JI, Nuhu K, McDaniel JT, Popoff F, Izcovich A, Criniti JM. Inequality as a Powerful 
Predictor of Infant and Maternal Mortality around the World. PloS one. 
2015;10(10):e0140796. doi:10.1371/journal.pone.0140796. 
12. Witter S, Adjei S, Armar-Klemesu M, Graham W. Providing free maternal health care: ten 
lessons from an evaluation of the national delivery exemption policy in Ghana. Global health 
action. 2009;2. doi:10.3402/gha.v2i0.1881. 
13. Perkins M, Brazier E, Themmen E, Bassane B, Diallo D, Mutunga A et al. Out-of-pocket 
costs for facility-based maternity care in three African countries. Health policy and planning. 
2009;24(4):289-300. doi:10.1093/heapol/czp013. 
  
14. Central Bureau of Statistics MoH, National AIDS Control Council, Kenya Medical 
Research Institute, National Council for Population and Development The DHS Program, ICF 
International. Kenya demographic and health survey, 2014. Nairobi, Kenya: Central Bureau 
of Statistics; 2015.  
15. Dickson KE, Simen-Kapeu A, Kinney MV, Huicho L, Vesel L, Lackritz E et al. Every 
Newborn: health-systems bottlenecks and strategies to accelerate scale-up in countries. 
Lancet. 2014;384(9941):438-54. doi:10.1016/s0140-6736(14)60582-1. 
16. WHO. Global Atlas of Health Work Force. Geneva: World Heath Organization; 2015.  
17. WHO. MDG Report by African Steering group. Geneva: World Health Organization; 2008. 
18. UNICEF. Committing to child survival: A Promise Renewed. Progress report 2013. New 
York: UNICEF; 2013.  
19. International HIV/AIDS Alliance. Community Responses to Injecting Drug Use and HIV. 
Good Practice Guide: HIV and Drug Use. Hove, United Kingdom: International HIV/AIDS 
Alliance; 2010. 
20. Armstrong G. Commentary on McFall et al. (2017): The need for harm reduction 
interventions that are effective for women who use drugs. Addiction. 2017;112(8):1488-9. 
doi:10.1111/add.13856. 
21. Sherman SG, Kamarulzaman A, Spittal P. Women and drugs across the globe: a call to 
action. The International journal on drug policy. 2008;19(2):97-8. 
doi:10.1016/j.drugpo.2008.01.002. 
22. Pinkham S, Malinowska-Sempruch K. Women, harm reduction and HIV. Reproductive 
health matters. 2008;16(31):168-81. doi:10.1016/s0968-8080(08)31345-7. 
23. Peters V, Liu KL, Dominguez K, Frederick T, Melville S, Hsu HW et al. Missed 
opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, 
pediatric spectrum of HIV disease cohort. Pediatrics. 2003;111(5 Pt 2):1186-91.  
24. Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Hagan H. Are females who inject drugs 
at higher risk for HIV infection than males who inject drugs: an international systematic 
review of high seroprevalence areas. Drug and alcohol dependence. 2012;124(1-2):95-107. 
doi:10.1016/j.drugalcdep.2011.12.020. 
25. Azim T, Bontell I, Strathdee SA. Women, drugs and HIV. The International journal on 
drug policy. 2015;26 Suppl 1:S16-21. doi:10.1016/j.drugpo.2014.09.003. 
26. Morrison CL, Ruben SM, Beeching NJ. Female sexual health problems in a drug 
dependency unit. International journal of STD & AIDS. 1995;6(3):201-3.  
27. Ayon S, Ndimbii J, Jeneby F, Abdulrahman T, Mlewa O, Wang B et al. Barriers and 
facilitators of access to HIV, harm reduction and sexual and reproductive health services by 
women who inject drugs: role of community-based outreach and drop-in centers. AIDS care. 
2017(Oct 25):1-8. doi: 10.1080/09540121.2017.1394965. [Epub ahead of print].  
28. Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. 
Education for information. 2004;22(2):63-75.  
29. Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injecting drug 
users: a review of published outcome data. Public health reports. 1998;113 Suppl 1:19-30.  
30. Bazeley P. Qualitative data analysis with NVIVO. London Sage; 2007. 
31. Bryman A. Social Research Methods. Oxford University Press; 2012. 
32. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in 
psychology. 2006;3(2):77-101.  
33. Shiferaw S, Spigt M, Godefrooij M, Melkamu Y, Tekie M. Why do women prefer home 
births in Ethiopia? BMC pregnancy and childbirth. 2013;13:5. doi:10.1186/1471-2393-13-5. 
  
34. Nakua EK, Sevugu JT, Dzomeku VM, Otupiri E, Lipkovich HR, Owusu-Dabo E. Home birth 
without skilled attendants despite millennium villages project intervention in Ghana: insight 
from a survey of women's perceptions of skilled obstetric care. BMC pregnancy and 
childbirth. 2015;15:243. doi:10.1186/s12884-015-0674-1. 
35. van Eijk AM, Bles HM, Odhiambo F, Ayisi JG, Blokland IE, Rosen DH et al. Use of 
antenatal services and delivery care among women in rural western Kenya: a community 
based survey. Reproductive health. 2006;3:2. doi:10.1186/1742-4755-3-2. 
36. Anastasi E, Borchert M, Campbell OM, Sondorp E, Kaducu F, Hill O et al. Losing women 
along the path to safe motherhood: why is there such a gap between women's use of 
antenatal care and skilled birth attendance? A mixed methods study in northern Uganda. 
BMC pregnancy and childbirth. 2015;15:287. doi:10.1186/s12884-015-0695-9. 
37. Mmusi-Phetoe RM. Social factors determining maternal and neonatal mortality in South 
Africa: A qualitative study. Curationis. 2016;39(1):1571. doi:10.4102/curationis.v39i1.1571. 
38. Armstrong CE, Martinez-Alvarez M, Singh NS, John T, Afnan-Holmes H, Grundy C et al. 
Subnational variation for care at birth in Tanzania: is this explained by place, people, money 
or drugs? BMC public health. 2016;16 Suppl 2:795. doi:10.1186/s12889-016-3404-3. 
39. Simpson M, McNulty J. Different needs: women's drug use and treatment in the UK. The 
International journal on drug policy. 2008;19(2):169-75. doi:10.1016/j.drugpo.2007.11.021. 
40. WHO. Everybody’s Business: Strengthening Health Systems to Improve Health 
Outcomes—WHO’s Framework for Action. Geneva: Wold Health Organization; 2007. 
41. Cavagnero E, Daelmans B, Gupta N, Scherpbier R, Shankar A. Assessment of the health 
system and policy environment as a critical complement to tracking intervention coverage 
for maternal, newborn, and child health. Lancet. 2008;371(9620):1284-93. 
doi:10.1016/s0140-6736(08)60563-2. 
42. Barasa EW, Maina T, Ravishankar N. Assessing the impoverishing effects, and factors 
associated with the incidence of catastrophic health care payments in Kenya. International 
journal for equity in health. 2017;16(1):31. doi:10.1186/s12939-017-0526-x. 
43. Olsen A, Banwell C, Madden A. Contraception, punishment and women who use drugs. 
BMC women's health. 2014;14:5. doi:10.1186/1472-6874-14-5. 
44. Pinkham S, Stoicescu C, Myers B. Developing effective health interventions for women 
who inject drugs: key areas and recommendations for program development and policy. 
Advances in preventive medicine. 2012;2012:269123. doi:10.1155/2012/269123. 
45. NASCOP. Kenya National Guidelines for the Comprehensive Management of the Health 
Risks and Consequences of Drug Use. Nairobi: National AIDS and STI Control Programme 
(NASCOP). Ministry of Health, Government of Kenya; 2013. 
46. Lassi ZS, Bhutta ZA. Community-based intervention packages for reducing maternal and 
neonatal morbidity and mortality and improving neonatal outcomes. The Cochrane 
database of systematic reviews. 2015(3):Cd007754. doi:10.1002/14651858.CD007754.pub3. 
47. Mbuagbaw L, Medley N, Darzi AJ, Richardson M, Habiba Garga K, Ongolo-Zogo P. Health 
system and community level interventions for improving antenatal care coverage and health 
outcomes. The Cochrane database of systematic reviews. 2015(12):Cd010994. 
doi:10.1002/14651858.CD010994.pub2. 
48. Haritavorn N. I am just a 'maae' (mother): experiences of mothers injecting drugs in 
Thailand. Sociology of health & illness. 2016;38(7):1167-79. doi:10.1111/1467-9566.12448. 
49. Mburu G, Ndimbii J, Ayon S, Mlewa O, Mbizvo M, Kihara C et al. Contraceptive use 
among women who inject drugs: Motivators, barriers and unmet needs. Women's 
  
Reproductive Health. 2018;5(2):99–116. 
doi:https://doi.org/10.1080/23293691.2018.1463737. 
50. Islam MM, Topp L, Conigrave KM, van Beek I, Maher L, White A et al. The reliability of 
sensitive information provided by injecting drug users in a clinical setting: clinician-
administered versus audio computer-assisted self-interviewing (ACASI). AIDS care. 
2012;24(12):1496-503. doi:10.1080/09540121.2012.663886. 
51. Chiovitti RF, Piran N. Rigour and grounded theory research. J Adv Nurs. 2003;44(4):427-
35.  
52. Etikan I, Musa SA, Alkassim RS. Comparison of convenience sampling and purposive 
sampling. American Journal of Theoretical and Applied Statistics. 2016;5(1):1-4.  
 
 
 
 
 
